-3456x1080.jpeg)
Zeytun Pharmaceuticals continues its commitment to quality, reliability, and compliance with international standards by renewing its ISO and GDP (Good Distribution Practice) certifications.
The meeting held in connection with the certification renewal was attended by Bahruz Shiraliyev, General Director of Zeytun Pharmaceuticals, along with representatives of the certification body. During the meeting, the renewed ISO and GDP certificates were officially presented to the company’s management.
The renewed certifications once again confirm that Zeytun Pharmaceuticals meets high international standards in the distribution of pharmaceutical products, storage and logistics processes, as well as customer satisfaction management and overall operational activities. The certification process was conducted by an independent international organization and covered the company’s core areas of operation.
The renewal of ISO standards demonstrates the systematic implementation of quality management principles, a customer-oriented approach, and continuous improvement within the company. The GDP certification, in turn, confirms full compliance with international requirements related to product safety, traceability, and quality preservation throughout storage and distribution processes.
This achievement reflects Zeytun Pharmaceuticals’ consistent efforts to comply with regulatory requirements, strengthen cooperation with international partners, and reinforce its position as a reliable partner in the healthcare sector.
For Zeytun Pharmaceuticals, quality is not only about compliance with standards, but also a key indicator of long-term trust and sustainable development. The company remains committed to operating in full alignment with international requirements in the future.